Quantcast
Last updated on April 20, 2014 at 21:20 EDT

Latest AxoGen Inc. Stories

2014-04-16 23:10:26

AxoGen, Inc. will report results for the first quarter ended March 31, 2014 on Wednesday, April 30, 2014 after the market closes. Alachua, Florida (PRWEB) April 16, 2014 AxoGen, Inc. (NASDAQ: AXGN), the emerging leader of the $1.6 billion U.S. peripheral nerve repair market, will report results for the first quarter ended March 31, 2014 on Wednesday, April 30, 2014 after the market closes. The Company will host a conference call and webcast for the investment community on Wednesday, April...

2014-03-12 23:24:47

Supports Growing Interest in Nerve Repair from Orthopedic Surgeons Alachua, FL (PRWEB) March 12, 2014 AxoGen, Inc. (NASDAQ: AXGN), the emerging leader of the $1.6 billion U.S. peripheral nerve repair market, is pleased to announce its participation at the American Academy of Orthopedic Surgeons (AAOS) 2014 Annual Meeting, March 11-15, 2014 at the Morial Convention Center in New Orleans, LA, Booth 5818. “Increasing demand for nerve repair product options from orthopedic surgeons makes...

2014-03-06 23:01:39

Company Reports Continued Progress in Nerve Repair Market, Will Hold Conference Call Today at 4:30 p.m. ET Alachua, FL (PRWEB) March 06, 2014 AxoGen, Inc. (NASDAQ: AXGN), the emerging leader of the $1.6 billion U.S. peripheral nerve repair market, announced financial results for the fourth quarter and full year ended December 31, 2013. Revenue for the quarter grew 46% to $3.0 million and for the year grew 42% to $10.9 million as compared to comparable periods. “AxoGen is...

2014-03-03 23:23:04

Nerve repair company AXGN to participate in investor conference in New Orleans Alachua, FL (PRWEB) March 03, 2014 AxoGen, Inc. (NASDAQ: AXGN), the only company completely focused on peripheral nerve repair, is scheduled to present at the 9th Annual Canaccord Genuity Musculoskeletal Conference on Tuesday, March 11, 2014 at 11:10am CT (12:10pm ET) at the Sheraton New Orleans Hotel. A live webcast and subsequent archived replay of the Company’s presentation may be accessed via the Investor...

2014-02-12 23:24:21

Nerve repair company to release results and host earnings call Alachua, FL (PRWEB) February 12, 2014 AxoGen, Inc. (NASDAQ: AXGN), the only company completely focused on peripheral nerve repair, will report results for the fourth quarter and full year ended December 31, 2013 on Thursday, March 6, 2014 after the market closes. The Company will host a conference call and webcast for the investment community on Thursday, March 6, 2014 at 4:30 PM ET. Investors within the United States...

2014-02-06 23:23:03

Peripheral nerve repair clinical data shared by study investigators at major hand and nerve surgery meetings Alachua, FL (PRWEB) February 06, 2014 AxoGen, Inc. (NASDAQ: AXGN), the only company completely focused on peripheral nerve repair, today announced that new data from the CHANGE Study and the Ranger® Study was presented by study investigators at the recent combined annual meetings of the American Association for Hand Surgery (AAHS), American Society for Peripheral Nerve (ASPN)...

2014-01-24 23:05:08

Company to participate in International Symposium on Peripheral Nerve Repair Alachua, FL (PRWEB) January 24, 2014 AxoGen, Inc. (NASDAQ: AXGN), the only medical products company completely focused on peripheral nerve repair, today announced the acceptance of a scientific presentation on nerve repair at the International Symposium on Peripheral Nerve Regeneration (ISPNR) 2014 Meeting. The symposium, being held in Torino, Italy, acts as a platform for presenting and discussing new...

2014-01-21 23:24:22

Peripheral Nerve Repair Company to provide business update Alachua, FL (PRWEB) January 21, 2014 AxoGen, Inc. (NASDAQ: AXGN), the only medical products company completely focused on peripheral nerve repair, today announced that Greg Freitag, AxoGen’s Chief Financial Officer and General Counsel, is scheduled to present at “TEN”; Noble Financial Capital Markets’ Tenth Annual Equity Conference at Club Med in Sandpiper Bay, Florida on Wednesday, January 22, 2014 at 8:30 am ET. A live...

2014-01-09 23:22:34

AxoGen Symposium to feature panel of renowned leaders in nerve repair Alachua, FL (PRWEB) January 09, 2014 AxoGen, Inc. (NASDAQ: AXGN), the only regenerative medicine company completely focused on peripheral nerve repair, today announced that it will sponsor a lunch symposium and panel discussion at the combined annual meetings of the American Association for Hand Surgery (AAHS), American Society for Peripheral Nerve (ASPN) and American Society for Reconstructive Microsurgery (ASRM)...

2014-01-06 23:03:04

Frost & Sullivan Innovation Award Highlights Significance of Avance® Nerve Graft for Peripheral Nerve Repair Alachua, FL (PRWEB) January 06, 2014 AxoGen, Inc. (NASDAQ: AXGN), the only regenerative medicine company completely focused on peripheral nerve repair, has been awarded the 2014 North American New Product Innovation Leadership Award for Peripheral Nerve Repair by the preeminent global research organization, Frost & Sullivan. The award is based on the findings of...